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1. Introduction 
Stress is the force on unit areas within a material that develops as a result of the externally applied 
force (Enciclopedia Britannica, 2011). 
When I wrote the first paper on the stress syndrome in 1936, I tried to demonstrate that stress (…) is 
clearly a definable biological and medical phenomenon whose mechanisms can be objectively identified 
and with which we can cope much better once we know how to handle it (…) Stress is the nonspecific 
response of the body to any demand, whether is caused by, or results in, pleasant or unpleasant 
conditions (Selye, 1985). 
Oxidative stress is defined as a persistent imbalance between antioxidants and pro-oxidants in favor 
of the latter, resulting in (often) irreversible cellular damages (Probiox, 2011). 
Nitrosative Stress: A condition that occurs when the production of highly reactive nitrogen-
containing chemicals, such as nitrous oxide, exceed the ability of the (...) body to neutralize and 
eliminate them. Nitrosative stress can lead to reactions that alter protein structure thus interfering 
with normal body functions (Oxford Dictionary of Sports Science & Medicine, 2007).  
The four quotations collected above illustrate confusion with the notion of stress. In physics, 
in Hooke's law, ‘stress’ means a force acting on an elastic material and producing a 
proportional amount of deformation, or strain. However, according to Selye, who 
introduced the notion of ‘stress’ into (bio)medicine, it is not a kind of force acting on an 
organism (such force is called ‘stressor’), but a response of an organism to such a force. In 
fact, Selye’s definition of ‘stress’ is more similar to the notion of ‘strain’ in Hooke's law. 
Contemporary uses of the term ‘stress’ in biomedical scientific literature are very diverse; 
the last two examples define stress as an imbalance which occurs inside a body and leads to 
its damage. These definitions are very different from Selye’s definition of stress. 
Several distinguished authors wrote reviews about oxidative and nitrosative stress, but 
many either did not define these terms at all, or defined them vaguely and indirectly. For 
example, in a recent review one of the most prominent biochemists working in the field of 
redox and free radicals biochemistry professor Barry Halliwell only listed reasons why 
tissue injury causes oxidative stress and what oxidative stress means in the context of 
human disease (Halliwell, 2009); it seems that he implicitly defined oxidative stress as a 
result of tissue injury (or, perhaps, response to it) rather than its cause. However most 
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authors, indeed, use terms ‘oxidative stress’ and ‘nitrosative stress’ to describe situations of 
persistent imbalance between production and removal of oxidising free radicals leading to 
their increased level and resulting in harmful effects on biological molecules, cells and 
tissues. For example professor Helmut Sies defined ’oxidative stress’ as a condition 
occurring when the generation of reactive oxygen species (ROS) in a system exceeds the 
system's ability to neutralize and eliminate them. This imbalance can result from a lack of 
antioxidant capacity caused by disturbance in production, distribution, or by an 
overabundance of ROS from endogenous sources or environmental stressors (Brenneisen et 
al., 2005; Sies, 1997). Shouldn't we conclude that oxidative stress is always linked to the 
damage of biological macromolecules and the disruption of cellular homeostasis? However, 
the title of the other paper from Sies's laboratory includes the phrase "Peroxynitrite 
signalling: (...) activation of stress-responsive pathways" (Klotz et al., 2002), which is 
suggestive of that cells not only receive harm from nitrooxidative stress but also can 
respond to in an orderly manner, which depends on circumstances and may be either 
positive or detrimental. 
Concise and amazingly fitting definition of the term ‘stress’ we found in the English-Polish 
dictionary (Stanislawski, 1999). This definition, translated back to English, reads the 
following: ‘stress is the pressure of circumstances’. In the case of oxidative and nitrosative 
stress the said circumstances are disturbances in the balance between production and 
removal of reactive forms of oxygen and nitrogen, most of which are free radicals. The 
amount of literature on this subject is so large, that its comprehensive review would require 
a multi-thousand-page book. In the present chapter we will concentrate on the following 
specific subjects: (1) why nitrooxidative stress is considered harmful, (2) cellular metabolism 
of reactive oxygen and nitrogen species, and (3) how nitrooxidative stress can contribute to 
some major neurodegenerative diseases.  
2. Free radicals 
The recent version of the International Union of Pure and Applied Chemistry (IUPAC) 
Recommendations on Nomenclature of Inorganic Chemistry (IUPAC, 2005), known as the  
Red Book, defines a radical as an atom or molecule with one or more unpaired electrons. 
An unpaired electron may be indicated in a formula by a superscript dot. A radical  
may have positive, negative or zero charge. Metals and their ions or complexes often 
possess unpaired electrons but, by convention, they are not considered to be radicals. The 
terms ‘radical’ and ‘free radical’ are frequently used interchangeably, although more 
correctly radicals may be called ‘free’ only when they can freely diffuse in their 
environment.  
The aforementioned definition is also strictly applicable to organic radicals, i.e. radicals 
containing carbon. However, we shall bear in mind that not long time ago such a view was 
difficult to accept. This was because, after many futile attempts to isolate carbon-containing 
radicals, XIX-century chemists concluded that carbon must always be tetravalent (i.e. form 
four bonds) and organic radicals cannot exist. Although the first organic free radical, the 
trityl (triphenylmethyl) radical (fig. 1), was discovered by Gomberg in 1900, for many years 
this discovery was viewed only as a curiosity (Henderson, 2000). Besides, trityl radical does 
not contain oxygen.  
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Fig. 1. Trityl (triphenylmethyl) radical. 
The concept of oxygen free radicals toxicity as the major contributor to various 
pathologies has been developed in the middle of XX century, at the intersection of studies 
on mechanisms of oxygen toxicity and on toxic effects of ionizing radiation. On one hand, 
it was already very well known that eukaryotic organisms cannot survive without 
oxygen, yet at the same time oxygen is toxic. This Janus-faced property of oxygen is 
sometimes called the ‘paradox of aerobic life’, or the ‘oxygen paradox’ (Fridovich, 1975). 
Toxic effects of exposure to oxygen at increased partial pressure, particularly evident in 
human central nervous system and lungs, have been described in the late XIX century, but 
after more than 50 years their mechanism remained unknown (Donald, 1947). On the 
other hand, harmful effects on living organisms of ionizing radiation, which become 
known shortly after its discovery (Inkret et al., 1995), were already explained, mostly by 
the intracellular radiolysis of water molecules into H+ and OH- radicals. These radicals 
either by itself cause oxidative damage to the cells, or further recombine to nascent toxic 
radicals such as superoxide.  
In 1954 the presence of free radicals in biological materials not subjected to ionizing 
radiation was discovered (Commoner et al., 1954). Almost at the same time Gershman, 
Gilbert and collaborators put forward a hypothesis that the majority of harmful effects of 
both oxygen and ionizing radiation could be attributed to the same mechanism, namely the 
formation of oxygen radicals (Gerschman et al., 1954). This hypothesis was later developed 
into the theory that oxygen radicals are continuously generated in all living cells, starting 
point of their cellular metabolism being the formation of superoxide radical anion 
(Fridovich, 1983). Halliwell and Gutteridge (1984) called this concept ‘the superoxide theory 
of oxygen toxicity’. Currently it is generally accepted that oxygen free radicals are 
ubiquitous in the living matter; they are continuously produced by a variety of reactions 
(enzymatic and nonenzymatic), and at the same time continuously removed by the other 
variety of reactions. Indeed, the generation of oxygen radicals in living cells is not a 
pathology, but the fundamental physiological phenomenon.  
Moreover, molecular oxygen (O2) by itself is a double radical (a biradical), having two 
unpaired electrons with parallel spin states. This arangement is quite fortunate, as it 
makes O2 a stable radical and prevents spontaneous ignition of carbon-based materials in 
the oxygen atmosphere. On the other hand, as a consequence, oxidation by molecular 
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oxygen can easily occur only by the transfer of single electrons. However, organic 
molecules which are substrates for biological oxidations do not contain unpaired 
electrons. Therefore molecular oxygen could accept a pair of electrons from an organic 
substrate only when one of the electrons of oxygen or one of the electrons from the 
donating substrate inverts its spin. This can happen, but would require a substantial 
activation energy.  
The solution utilised by living cells to decrease activation energy for oxidations relies on 
conducting two oxidations stepwise, by a close sequence of two single-electron transfers 
(Miles, 2003). This arrangement works nicely, but its side effect is a relatively high 
probability that products of the first one-electron reduction of oxygen, i.e. oxygen radicals, 
will not engage in the second one-electron reduction step but enter the intracellular (or 
extracellular) milieu instead. 
As mentioned already, oxygen free radicals have potential to react with (that is, to oxidize) 
practically any organic molecule they come in contact with. These reactions may inflict 
damage to cellular constituents including macromolecules (proteins, nucleic acids), 
aminoacids, sugars, lipids (polyunsaturated fatty acids in particular) etc. However, under 
normal metabolic conditions the actual concentration of free radicals in biological matter 
(i.e. living cells and extracellular material) is pretty small. Chance et al. (1979) estimated that 
in rat liver equilibrium concentration of superoxide anion radical is in the order of 10-12 to 
10-11 M and that of hydrogen peroxide is only 3 orders of magnitude greater. Only if 
equilibrium is disturbed, which may be called nitrooxidative stress, oxygen free radicals and 
products of their metabolism which are strong oxidants, all called collectively reactive 
oxygen and nitrogen species (ROS and RNS), do have potential for inflicting damage to vital 
constituents of the living cells (McCord, 2000).  
3. Cellular metabolism of reactive oxygen and nitrogen species 
Reactions of ROS and RNS which occur in living cells are irreversible and may be presented 
as a cascade (fig. 2) that starts with generation of superoxide radical (O2-). This free radical 
appears mainly in mitochondria; some authors estimate that 2-4% of oxygen metabolized by 
mitochondrial respiratory chain leaves it as superoxide (Turrens, 2003). O2- is also a product 
of certain enzymatic reactions localized outside mitochondria, in particular NADH 
oxidation conducted by non-mitochondrial NADH oxidases called NOX (Sorce & Krause, 
2009). Some NOX isoenzymes are end parts of ‘plasma respiratory chains’ called also 
’plasma membrane oxidoreductases’ (PMOR) present in many cell types including neurons 
(Wright & Kuhn, 2002). ECTO-NOX present on cell surface are supposed to release O2- into 
the extracellular milieu, while other isoforms of NOX produce superoxide radical 
intracellularly. 
An additional source of superoxide radical is singlet oxygen (1O2), generated in 
photosensitization reaction which takes place in vivo upon exposure of cells to light, e.g. in 
the retina. Although not a free radical, 1O2 is a highly reactive molecule, thus it belongs to 
ROS. Some authors claim that singlet oxygen by itself can damage membranes and other cell 
components (Winkler et al., 1999). Importantly, singlet oxygen cannot be removed 
enzymatically but only in reactions with non-enzymatic antioxidants. Singlet oxygen can be 
also reduced to O2-.  
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Fig. 2. Cascade of radical reactions in the cell and the most important reactive oxygen and 
nitrogen species. Main sources of ROS and RNS are listed in the upper part of the figure. 
Reproduced from Mangialasche et al. (2009). © Elsevier, with permission. 
Cells can be damaged directly by superoxide radical (Benov, 2001), or by its metabolites, 
hydroxyl radical and peroxynitrites. Compared to other radicals superoxide is not very 
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reactive chemically; moreover it may react only either with itself (dismutation), with another 
radical such as nitric oxide, or with a a metal. Hovewer, although dismutation of O2- occurs 
spontaneously, it is a second order reaction with respect to substrate concentration, 
ineffective in removing it at low concentrations. Since even in subnanomolar concentrations 
superoxide is toxic, in particular to some mitochondrial enzymes (e.g. aconitase), all cells are 
equipped with enzymes superoxide dismutases (SOD), which very efficiently convert 
superoxide to hydrogen peroxide (see below). 
Of all ROS, hydrogen peroxide is a molecule with the longest half-life, and it may achieve 
the highest intracellular concentration. Moreover, it has the ability to diffuse across 
biological membranes. Hydrogen peroxide by itself is not particularly toxic or dangerous to 
the cells, but in reaction catalyzed by iron ions (Fe2+) it is converted to hydroxyl radical 
(OH) (Buonocore et al., 2010). This reaction, known as the Haber-Weiss reaction, generates 
hydroxyl radicals from H2O2 and superoxide. It can occur in cells, being responsible for 
oxidative stress. It is a two-step catalytic cycle. The first step involves reduction of ferric ion 
to ferrous: 
Fe3+ + O2− → Fe2+ + O2 
The second step, known as the Fenton reaction, regenerates ferric ion: 
Fe2+ + H2O2 → Fe3+ + OH− + OH 
Hydroxyl radical is regarded the most cell-damaging oxidant (Cheng et al., 2002). Its half 
life is extremely short (10-6 s, 3 orders of magnitude shorter than O2−) and it acts locally, 
very close to site of its generation. It reacts mainly with alkyl groups or with 
polyunsaturated fatty acids, initiating chain peroxidation (see below). 
Peroxynitrite (ONOO-), the most important RNS, is a product of reaction of superoxide 
radical with nitric oxide. It is not a radical but is a potent oxidant and nitrating agent. It 
can nitrate tyrosine residues of proteins (generating nitrotyrosine) – this protein 
modification can affect enzyme activities and increase susceptibility of proteins to 
proteolysis (Abello et al., 2009). It also oxidizes fatty acids and induces DNA strand 
breaks (Ascenzi et al., 2010). 
ROS and RNS react with many important biomolecules. Lipid chain peroxidation is 
particularly important since it affects functioning of biological membranes: their fluidity, 
permeability, ion transportation and inhibits metabolic processes. Peroxidation of 
mitochondrial membrane lipids (e.g. cardiolipin) may induce apoptosis (Kagan et al., 2009). 
Lipids containing polyunsaturated faty acids (PUFA) are particularly vulnerable to 
peroxidation. Lipid chain peroxidation consists of three phases: initiation, propagation and 
termination (fig. 3). Initiation phase includes hydrogen atom abstraction in reaction with 
diiferent radicals (e.g. OH) and produces a lipid radical (L). L reacts with oxygen to 
produce lipid peroxyl radical (LOO) that can abstract hydrogen atoms from another lipids 
to produce lipid hydroxyperoxide (LOOH) and another radical (propagation). This reaction 
can repeated many times – one hydroxyl radical can damage thousands of PUFA chains. 
The ‘chain peroxidation’ terminates when two radicals react together forming non-radical 
species (Catala, 2010).  
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Fig. 3. Lipid peroxidation mechanism. Arachidonic acid was used as an example. 
Reproduced from Catala (2010). © Elsevier, with permission. 
Cells possess various mechanisms responsible for minimizing free radical hazard – ‘low-
weight’ non-catalytic antioxidants and antioxidant enzymes. Superoxide dismutases can be 
regarded as ‘first line of defense’ against ROS. This group of enzymes catalyze reaction of 
superoxide radical dismutation (i.e. conversion of O2- to H2O2). Although this reaction 
occurs spontaneously, lack of catalyst would increase O2- concentration, potentiate chain 
lipid peroxidation and lead to more intensive generation of RNS. Mammals possess three 
isoforms of superoxide dismutases: ‘cytoplasmic’ (CuZn-SOD, SOD1), ‘mitochondrial’ (Mn-
SOD, SOD2) and ‘extracellular’ (EC-SOD, SOD3). Most of cellular dismutase activity (50-
80%) is attributed to SOD1 (Faraci & Didion, 2004) but it is SOD2 that is thought to be 
crucial for cell functioning. SOD2 gene knockout was lethal in mice (Huang et al., 2001) and 
decrease in SOD2 activity (Sod2+/-) led to neuronal loss and cancer progression (Van 
Remmen et al., 2003). 
It should be also stressed that recently ROS and RNS are regarded not only as toxic 
byproducts of metabolism but also as important signaling molecules. Two important and 
thoroughly examined ones are hydrogen peroxide and nitric oxide. Hydrogen peroxide has 
relatively long half-life and can penetrate biological membrane. Concentration of H2O2 in 
the cell is also relatively high. It is believed to be involved in various processes including 
immune cell activation, remodeling of vessels, cell growth and many others (see reviews by 
Veal et al. (2007) or by Giorgio et al. (2007)). Hydrogen peroxide level is precisely regulated 
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by growth factors. It inhibits phosphatases that are involved in propagation of signal 
induced by growth factors. It also induces tyrosine phosphorylation by activation of MAP 
kinases. 
Observation that at least some of ROS and RNS are important signaling molecules and their 
levels are precisely regulated in the cell leads to the idea of ‘redox homeostasis’. It is 
hypothesized that ROS/RNS are especially involved in regulation of proliferation and cell 
death of cells (Clement & Pervaiz, 1999). Reducing environment and low levels of ROS/RNS 
would suppress proliferation and is characteristic for ‘resting’ cells (see also fig. 7). Higher 
level of oxidants would promote proliferation and a bit higher apoptosis. However, above 
some range apoptosis would be suppressed due to oxidation of caspases (Hampton & 
Orrenius, 1998). 
4. Nitrooxidative stress – Contribution to the pathomechanisms of 
neurodegenerative disorders 
Neurodegenerative diseases – innate or acquired disorders of nervous system – can be 
defined by degeneration and death of neuronal cells. There is a regional or even cell-type-
specific selectivity of neuronal failure and loss in different diseases. For example in 
Alzheimer’s disease loss of cholinergic neurons occur mainly in the forebrain, in Parkinson’s 
disease dopaminergic neurons in substiantia nigra are selectively injured and in glaucoma 
retinal ganglion cells are degenerating. Neuronal tissue seems to be vulnerable to damage 
caused by reactive forms of oxygen and nitrogen: oxygen metabolism is high and neurons 
contain high amounts of PUFA. Also oxidative/nitrosative damage to the neuronal tissue 
seems to be an early hallmark of degeneration in different pathologies. Thus, despite region-
specific sensitivity, damage resulting from processes including ROS and RNS may be 
proposed as unifying mechanism for neurodegeneration (Ischiropoulos & Beckman, 2003). 
Common mechanisms involved in neurodegenerative disease leading to oxidative stress 
could include the inhibition of mitochondrial metabolism, neuronal excitotoxicity, and 
neuroinflammation (Golden & Patel, 2009). Examples further in this chapter show that 
nitrooxidative stress can be a key player in pathomechanisms of diverse neurodegenerative 
diseases. 
4.1 Nitrooxidative stress and Alzheimer’s disease 
Alzheimer’s disease (AD) is the most common type of dementia and in fact the most 
common neurodegenerative disorder. Most of the cases are sporadic but 5-10% of cases are 
familial and associated with mutations in genes of proteins involved in amyloid-ǃ (Aǃ) 
metabolism. The disease is characterized by progressive cognitive decline and 
neuropathological alterations: senile plaques built up by Aǃ peptide and neurofibrillary 
tangles composed of hyperphosphorylated tau protein. Gross brain atrophy prominent in 
AD is caused by massive loss of neurons mostly in the temporal lobe and parietal lobe, and 
parts of the frontal cortex and cingulate gyrus. Possibilities of therapeutic interventions are 
currently modest. 
Numerous reports demonstrate both oxidative and nitrosative damage in the brains of AD 
patients (reviewed by Mangialasche et al. (2009)). This damage concerns lipids since 
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numerous markers of lipid peroxidation (inter alia malondialdehyde, acrolein, 4-hydroxy-2-
nonenal and F2-isoprostanes) were found to be upregulated in brains of AD patients. Also 
markers of nucleic acid damage (like 8-hydroxydeoxyguanosine) or protein modification 
(like 3-nitrotyrosine (3-NT) or protein carbonyls) were upregulated. 
 
 
Fig. 4. Overview of the interplay between Aǃ, Tau, oxidative/nitrosative stress, and 
mitochondria. Reproduced from Bobba et al. (2010). © Antonella Bobba et al., open access 
article.  
Importantly, increased oxidative damage seems to be an early event in AD pathology 
since it is observed already in mildly cognitively impaired patients (Keller et al., 2005). 
This observations led to an idea of using various markers of oxidative/nitrosative damage 
as an early marker of AD pathology allowing to start therapeutical intervention in  
an early stage of the disease (see review by Galasko & Montine (2010)). Currently,  
F2-isoprostane, a lipid peroxidation product, seems to be the most promising biomarker 
(de Leon et al., 2007; Pratico et al., 2002). Unfortunately while distinguishing AD and  
non-AD patients with markers measured in the cerebrospinal fluid seems to be pretty 
reliable there are some problems with applying these measures to plasma or urine 
samples.  
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Results obtained in different animal models of AD are consistent with those observed in 
patients. Oxidative lipid damage seem to be an early event in transgenic mouse models of 
AD amyloidosis and in fact precede Aǃ plaque formation (Pratico et al., 2001).  
One simple explanation of increased nitrooxidative stress in AD is Aǃ toxicity. This is in 
concert with Aǃ hypothesis that is currently the most popular one and assumes that 
formation of Aǃ plaques is a central event in AD patophysiology. Aǃ is thought to be 
capable of forming of free radicals by generation of hydrogen peroxide (Jomova et al., 2010). 
This potential of Aǃ to generate free radicals was confirmed by in vitro studies (Ill-Raga et 
al., 2010) and is connected with its affinity to redox metals (eg. copper and iron). From the 
other side in experimental models nitrooxidative stress precedes Aǃ plaques formation. 
There is also data showing that oxidative stress can actually alter metabolism of Aǃ 
precursor protein and tau and thus promote formation of plaques and tangles (Li et al., 2004; 
Lovell et al., 2004; Ohyagi et al., 2000).  
An apparent hallmark of AD is decreased brain energy metabolism. Even when corrected 
for decreased number of neurons brain glucose metabolism is markedly decreased in AD 
patients (Heiss et al., 1991; Ogawa et al., 1996). This altered energetics may be attributed to 
mitochondrial dysfunction and promote production of ROS and RNS. Recent reports 
showed that it could be Aǃ that affects mitochondria and alters their functioning. Aǃ can 
access the mitochondrial matrix and accumulate in the mitochondria affecting activity of 
mitochondrial enzymes and potentiate release of ROS (Chen & Yan, 2006). 
Last but not least inflammatory processes seem to be a part of AD pathology - microglia are 
present in the Aǃ plaques and in their surroundings (Rozemuller et al., 2005; Schwab & 
McGeer, 2008). Also Aǃ can in vitro activate microglia (Jekabsone et al., 2006). Activation of 
microglia is associated with production of ROS and potentially leads to damage of 
neighbouring neurons (Block et al., 2007). 
4.2 Nitrooxidative stress and Parkinson’s disease 
Parkinson’s disease (PD) is the second most common neurodegenerative disease. Disease 
progression starts with motor deficiencies – rigidity, shaking, slowness of movement and as 
progresses difficulties with gait and walking arise. In the advanced stages of the disease 
symptoms also include cognitive decline and behavioural changes. Pathologic hallmarks of 
PD are degeneration and death of dopaminergic neurons in substantia nigra and presence of 
Lewy bodies – intracellular aggregates of protein ǂ-synuclein. Treatment includes 
stimulation of dopamine signalling, e.g. by supplementation with dopamine precursor – L-
DOPA or by administration of dopamine agonists (Lew, 2007).  
Nitrooxidative stress is evident in the brains of PD patients. Increased levels of lipid 
peroxidation products: 4-hydroxy-2-nonenal and thiobarbituric acid reactive substances 
were found in substantia nigra of PD patients (Yoritaka et al., 1996). Also markers of 
oxidative damage to DNA and RNA like 8-hydroxyguanosine were found to be 
upregulated in this region (Zhang et al., 1999). Protein oxidation was found to be 
increased in PD, eg. levels of protein carbonyls were higher than in age-matched controls 
(Alam et al., 1997). 
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Also data obtained from animal models of PD imply increased nitrooxidative stress. PINK1 
and DJ-1 null mice had increased levels of oxidative stress markers (Andres-Mateos et al., 
2007; Gautier et al., 2008). Toxicity of overexpressed ǂ-synuclein in mice is also thought to 
be associated with free radicals (Masliah et al., 2000). 
 
Fig. 5. Oxidative and nitrosative stress as a central event in PD pathology. SNc – substantia 
nigra compacta. Reproduced from Tsang & Chung (2009). © Elsevier, with permission. 
This upregulation of oxidative/nitrosative stress might be related to mitochondrial 
dysregulation observed in PD patients (see fig. 5). There is direct evidence showing 
decreased activity of mitochondrial complex I isolated from substantia nigra and frontal 
cortex of PD patients (Parker, Jr. et al., 2008; Schapira et al., 1990). Also increased oxidation 
of this protein complex has been shown in PD patients (Keeney et al., 2006). It seems that 
abnormalities in functioning of complex I lead to increased generation of ROS. Importantly, 
administration of several complex I inhibitors lead to PD symptoms: motor deficiencies and 
death of dopaminergic neurons. Accidental exposure to 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP, impurity in illegally synthesized recreational drug 1-methyl-4-
phenyl-4-propionoxypiperidine, MPPP) that is precursor of neurotoxic 1-methyl-4-
phenylpyridinium (MPP+) leads to a rapid development of irreversible parkinsonian 
symptoms (Langston et al., 1983). Due to its selectivity, MPTP administration to laboratory 
animals is widely used as a model of PD. On the other hand ROS and RNS might be 
involved in decrease of complex I activity especially by involvement of ONOO- (Navarro & 
Boveris, 2009). 
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Overstimulation of N-methyl-D-aspartate receptor (i.e. excitotoxicity) can be also involved 
in PD pathology. Resulting Ca2+ influx leads to activation of NO synthase and 
overproduction of NO that can react with O2- (overproduced due to mitochondrial 
dysregulation) and generate highly toxic ONOO-. This mechanism seems to work in mice 
treated with MPTP since various NO synthase knockout mice were resistant to MPTP 
toxicity (Liberatore et al., 1999; Przedborski et al., 1996). 
Activation of microglia is also present in PD pathology. Such activation was observed in PD 
patients in vivo by PET imaging (Gerhard et al., 2006). It was also noted in the brains of 
MPTP-intoxicated patients (Langston et al., 1999) and in animals that received MPTP in 
order to induce PD symptoms (Czlonkowska et al., 1996; Kohutnicka et al., 1998). One link 
between this persistent activation of microglia and pathology is increased production of 
ROS/RNS. 
4.3 Nitrooxidative stress and glaucoma 
Glaucoma – neurodegenerative disease of the retina – is the most common cause of 
irreversible blindness worldwide (Resnikoff et al., 2004). Progression of glaucoma is 
associated with gradual narrowing of visual field, typically starting from the periphery. It 
is sometimes called ‘a sneaky theft of sight’ since progression of the disease may remain 
unnoticed for many years. Pathological changes in glaucoma concern retinal ganglion 
cells and its axons that build optic nerve (Foster et al., 2002). Some recent data point that 
glaucoma is not limited to retina and optic nerve but also affect upstream components of 
the visual pathway (Gupta & Yucel, 2007). Current treatment strategies concentrate on 
lowering intraocular pressure (IOP), a condition observed in most but not all of the cases 
of glaucoma. 
Measuring nitrooxidative damage biomarkers is a bit easier in case of glaucoma as aqueous 
humor and vitreous humor are pretty easily accessible. MDA level was two times higher in 
aqueous humor obtained from patients with open angle glaucoma than from healthy 
controls (Ghanem et al., 2010; Yildirim et al., 2005). Also open angle glaucoma patients had 
higher level of oxidative DNA damages in cells of trabecular meshwork (structure engaged 
in control of IOP). Importantly these alterations correlated well with IOP and narrowing of 
visual field (Izzotti et al., 2003; Sacca et al., 2005). Glutathione, ascorbic acid and tyrosine – 
low molecular antioxidants were downregulated in glaucoma patients (Ferreira et al., 2004), 
whereas SOD activity was diminished. 
Also in animal models of glaucoma markers of oxidative/nitrosative stress were 
upregulated. MDA was upregulated in a model of high-pressure glaucoma (Moreno et al., 
2004). Also carbonyl groups in retinas from these animals were upregulated. SOD activity in 
a model of high-pressure glaucoma was diminished (Moreno et al., 2004). 
Signs of mitochondrial dysregulation were also noted in glaucoma patients. Abu-Amero et 
al. (2006) revealed association between primary open-angle glaucoma and changes in 
mitochondrial DNA. They also found that mitochndrial respiratory activity was 
significantly decreased in these patients. In normal tension glaucoma mutations in genes 
coding mitochondrial proteins were found (Mabuchi et al., 2007; Wolf et al., 2009).  
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Fig. 6. Multiple proposed pathogenic mechanisms in glaucoma seem to related to oxidative 
stress as a common pathway. Reproduced from Tezel (2006). © Elsevier, with permission. 
It is well known that glutamate administered into vitreous humor is toxic for retinal 
ganglion cells (Lucas & Newhouse, 1957; Quigley, 1999). Also N-methyl-D-aspartate 
intravitreous administration causes massive retinal ganglion cell loss (Nakazawa et al., 
2005). The ability of glial cells to buffer extracellular glutamate might be impaired (Martin et 
al., 2002; Moreno et al., 2005). Although, some earlier reports demonstrated elevated 
glutamate in glaucoma patients and in some glaucoma models (Brooks et al., 1997; Dkhissi 
et al., 1999; Dreyer et al., 1996), other groups did not observe glutamate elevation in similar 
settings (Carter-Dawson et al., 2002; Honkanen et al., 2003). 
Immune component is also present in glaucoma (Tezel, 2011). Upregulation of different 
components of immune system was found in glaucoma patients (Kuehn et al., 2006; Wax et 
al., 1998; Yang, 2004). Also in various animal models immune response was upregulated 
(Johnson et al., 2007; Steele et al., 2006). So called ‘para-inflammation’ – weak but persistent 
activation of immune system seem to be the case in glaucoma. Oxidized macromolecules 
stimulate resident immune cells including microglia and seem to stimulate para-
inflammation (Xu et al., 2009). 
5. Antioxidant therapies in neurodegenerative diseases: Rationales and 
precautions 
As shown above, ROS and RNS could be regarded as ‘key players’ in pathologies of 
various neurodegenerative diseases. This leads to idea that antioxidant supplementation 
can be a reasonable therapeutic strategy in neurodegenerative disorders. One can imagine 
two major strategies to reduce nitrooxidative stress in these pathologic conditions (Uttara 
et al., 2009): 
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- ‘upstream’ to nitroxidative stress 
- ‘downstream’ to nitrooxidative stress 
‘Upstream’ antioxidant therapies would lead to reduction of ROS/RNS production. This 
could be achieved by chelating metals that catalyze generation of free radicals (like hydroxyl 
radical), inhibition of enzymatic reactions leading to generation of ROS/RNS or its 
precursors (e.g. hydrogen peroxide or nitric oxide). ‘Downstream’ antioxidant therapies 
would include agents reducing or preventing inflammation but also direct antioxidants, i.e. 
‘antioxidants’ in traditional and narrow meaning. Some examples of antioxidants are listed 
in table 1. 
 
 Mechanism of action Examples 
Upstream 
antioxidants 
Preventing formation of free 
radicals 
- Chelators 
- Inhibitors of oxidases 
- Inhibitors of nitric oxide synthase 
- Antagonists of glutamate 
receptors 
- Calcium antagonists 
- Anti-inflammatory drugs 
Downstream 
antioxidants 
Scavenging free radicals (direct 
antioxidants) 
- Tocopherols 
- Flavonoids 
- Selenium-containigs compounds 
(e.g. ebselen) 
- Polyenes  
(carotene, lycopene, retinol) 
Catalizing decomposition of free 
radicals 
- Mimetics of superoxide 
dismutase and/or catalase  
(e.g. tempol) 
Preventing secondary burden by 
ROS/RNS 
- Creatine 
- Carnitine 
- Lipoic acid 
- Nicotinamide 
- N-butyl-ǂ-phenylnitrone 
Table 1. Examples of upstream and downstream antioxidants. 
Many of the known antioxidants were tested in various animal models of 
neurodegenerative diseases and some of them were also tested in clinical trials (see reviews 
by (Moosmann & Behl, 2002; Tan et al., 2003; Uttara et al., 2009)). It is hard to summarize 
this data but one has to admit that outcomes are somehow disappointing. Theoretically, the 
best we can expect in case of antioxidant therapy in neurodegenerative diseases is cessation 
of degenerative processes. This means that we can count on stopping the process that is 
normally already pretty advanced, in many diseases the first symptoms appear only when 
40-50% of cells are lost.  
Another lesson from these numerous studies concerns features which should characterize an 
antioxidant that could be potentially protective in neurodegenerative diseases. Ability to 
cross the brain-blood barrier (BBB) seems to be the crucial one (Gilgun-Sherki et al., 2001). 
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Many of the known antioxidants have poor ability to cross BBB. The way the molecule 
crosses BBB can be also of importance, e.g. vitamin C is transported as its oxidised form, 
dehydroascorbic acid, by glucose transporter and then reduced back to ascorbic acid. 
However, reducing dehydroascorbic acid consumes glutathione. This means that vitamin C 
supplementation would not lead to increase in the net cerebral antioxidant capacity (Tan et 
al., 2003).  
There are some issues and controversies concerning antioxidant therapies per se. For years 
antioxidants used to be shown unequivocally as safe and widely applicable drugs. 
However, recent clinical trials suggest more careful approach to antioxidant application. In 
some cases they can even potentiate the damage (Halliwell, 2000; Salganik, 2001). One of the 
many possible reasons is that ROS and RNS are not only damaging agents but as mentioned 
before also play a vital signalling role in the cell. Cells and organisms maintain redox 
homeostasis and too low levels of ROS and RNS can also be detrimental. Potential side-
effects of antioxidants are summarised in fig. 7. 
 
Fig. 7. Potential side-effects of antioxidants. Antioxidants might: (1) inhibit cell proliferation 
by preventing transient oxidations that stimulate protein phosphorylation and transcription 
factors; (2) protect against oxidative damage by scavenging excess ROS/RNS; (3) prevent 
adaptation to oxidative damage by decreasing transcription-factor activation; (4) accelerate 
oxidative damage by reducing transition-metal ions into their lower oxidation states that are 
better promoters of free-radical damage; and (5) inhibit free-radical-induced apoptosis, 
either beneficial to the organism or deleterious. Reproduced from Halliwell (2000).  
© Elsevier, with permission. 
Good examples illustrating are mimetics of SOD, e.g. TEMPOL and other nitroxides, stable 
radicals that convert superoxide radical to hydrogen peroxide. Administration of substances 
that would help in eliminating superoxide radical seems to be a good therapeutic strategy 
and proved to be effective in many settings (Wilcox, 2010). On the other hand deleterious 
effects of SOD overexpression are well known, as they have been demonstrated in many 
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settings including cell lines (Groner et al., 1986) and transgenic animals (Avraham et al., 
1988; Ceballos-Picot et al., 1991). Increased oxidative stress in Down’s syndrome seems to be 
associated with SOD-1 overexpression (Sinet, 1982). Dose-dependency curve for SOD and 
also its mimetics in different experimental settings is ‘bell-shaped’, i.e. after reaching 
maximum protective effect further increasing the dose leads to decreasing the protective 
effect (McCord, 2008). 
6. Conclusions 
Nitrooxidative stress seems to be not only a common phenomenon in various 
neurodegenerative disorders, but also a common mechanism of neurodegeneration. 
Obviously, there are ‘disease-specific’ factors that activate and inter-play with nitrooxidative 
stress but neurodegenerative diseases seem to share some factors that are ‘key players’ in 
their pathology: excitotoxicity, mitochondrial disruption and neuroinflammation.  
Antioxidant supplementation seemed to be an excellent therapeutic and prophylactic 
strategy for various neurodegenerative disorders. Recently, antioxidant supplementation 
occurred not as safe as we previously thought. Also efficacy of these therapies is somehow 
controversial. Perhaps we need antioxidants that are precisely ‘targeted’ and evaluate 
accurate dosing of these substances. 
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